Diax Lab’s industry-leading clinical toxicology testing of urine, saliva and blood accurately confirms whether patients are compliant with their drug therapies, providing an important layer of protection for physicians to verify usage compliance, adjust treatment or terminate drug therapy to protect patients from harm and prescribing physicians from potential legal exposure.
→ Sixty-three percent of Americans taking prescription drugs strayed from their physician’s treatment plan and three in five were taking medications that weren’t prescribed, according to a Stanford Medicine study. Nearly one-third has stopped taking a prescribed drug without talking to their health care provider, according to an NPR poll. Further, a review in the Annals of Internal Medicine revealed that 20-30% of prescriptions are never filled and nearly 50% of chronic disease medications are not taken as prescribed.
→ Opioid addiction steals 54,600 American lives every year, and deaths associated with drug overdose, including prescription opioids and illicit drugs, has increased twofold in a decade. In addition to the unnecessary loss of life, opioid misuse is threatening the future of the physicians writing opioid prescriptions.
→ Opioids – prescription opioids, heroin and synthetic opioids – are involved in two of every three drug overdose deaths, underlining the importance of regular prescription drug monitoring.
Our toxicology testing, extensive monitoring and chronic care management solutions are critical to your medical practice in following federal compliance standards, regulations that require regular patient follow-up testing, and retractable pain laws and guidelines, which vary by state, to protect physicians who legitimately prescribe opioids to patients needing chronic pain management.
Our sweeping 27 panel test includes extensive subcategories to detect opioids, illicit drugs and harder-to-detect designer drugs.
Opioids and Opiate Analogs